Clinical Trial Update: Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing chiglitazar to placebo in adults with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chiglitazar (Chiglitazar)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED